Flexion Therapeutics: Flexin' Its Price Target


  • What is Flexion Therapeutics (NASDAQ:FLXN) and Zilretta?
  • Why is Zilretta Better?
  • Safety and JAMA Article
  • The Osteoarthritis Market
  • Risk to Reward
  • Financials
  • Summary

What is Flexion Therapeutics?

Pronounced Flex-shun, the company is based around a slow-release formulation and delivery platform. Currently, it is nearly 100% focused on its lead candidate Zilretta, but its technology is adaptable to many site-specific, slow-release formulations. The fundamental technology behind Flexion is its "microsphere" technology, or small beads which house active drugs.


It's on us. Share your news here.

Submit your stories and articles to citybizlist today.